Nektar Therapeutics (NKTR) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Nektar Therapeutics (NKTR) Company Statistics | The Fly

Nektar Therapeutics

· NKTR

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

1.645 B

-18.69%

General

Market Cap: $2.02B
Enterprise Value: $1.46B
Shares Outstanding: 33,790,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 99.36%
Operating Margin: -240.38%
Net Profit Margin: -287.84%
FCF Margin: -428.75%
ROA: -14.35%
ROE: -37.99%
ROIC: -12.53%
Current Ratio: 10.42
Debt-to-Equity: 0.15
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 24.98
P/FCF: —
P/B: 1.51
EV/EBITDA: -10.87

Growth

Rev 1Y: -43.89%
Rev 1Y Fwd Est: -24.18%
Rev 3Y (CAGR): -15.66%
Rev 5Y (CAGR): -18.43%
Rev 10Y (CAGR): -13.32%
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $54.59M
Gross Margin: 99.36%
Operating Expenses: $185.46M
Operating Income: -$131.22M
Net Profit: -$157.13M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $39.11M
Working Capital: $668.42M
Total Assets: $1.1B
Net Debt: $96.83M
Total Liabilities: $192.01M
Total Equity: $903.12M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$233.79M
Cash Flow from Investing: -$844.4M
Cash Flow from Financing: $1.07B
Free Cash Flow: -$234.05M
Capital Expenditures: $262K